[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condbio:chronic-lymphocytic-leukemia:hla-complex":3},{"condition":4,"biomarker":5,"total":6,"trials":7},"Chronic Lymphocytic Leukemia","HLA Complex",7,[8,16,22,29,35,42,48],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT07284433","Study of Allo-QuadCAR01-T, an Allogeneic CAR-T Targeting CD19\u002FCD20, in Patients With Relapsed or Refractory B-Cell Malignancies",[12],"Phase 1\u002FPhase 2","RECRUITING","2026-08-26T02:17:25.718160Z","2026-05-05T02:43:26.758756Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":20,"content_modified":21},"NCT05470491","Trial of Allogeneic Reduced-Intensity, HLA-Haploidentical Allogeneic Hematopoietic Cell Bone Marrow Transplantation Followed by Graft-versus-Host-Disease (GVHD) Prophylaxis With Cyclophosphamide, Bortezomib and Maraviroc for Hematologic Malignancies ...",[12],"2026-08-26T02:17:35.666428Z","2026-05-05T02:43:29.587324Z",{"nct_id":23,"title":24,"phases":25,"status":13,"updated_at":27,"content_modified":28},"NCT05031897","Two Step Haplo With Radiation Conditioning",[26],"Phase 2","2026-08-26T02:16:32.589113Z","2026-05-05T02:43:29.158573Z",{"nct_id":30,"title":31,"phases":32,"status":13,"updated_at":33,"content_modified":34},"NCT06059391","CMV-MVA Triplex Vaccination in HLA-Matched Related Stem Cell Donors for the Prevention of CMV Infection in Patients Undergoing Hematopoietic Stem Cell Transplant",[26],"2026-08-26T02:16:01.910993Z","2026-05-05T02:35:31.868600Z",{"nct_id":36,"title":37,"phases":38,"status":13,"updated_at":40,"content_modified":41},"NCT07020533","A Vaccine (CMV-MVA Triplex Vaccine) for the Enhancement of CMV-Specific Immunity and the Prevention of CMV Viremia in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplant",[39],"Phase 1","2026-08-26T02:18:31.944757Z","2026-05-05T02:43:28.960514Z",{"nct_id":43,"title":44,"phases":45,"status":13,"updated_at":46,"content_modified":47},"NCT03986034","Early Clonal Dynamics During Venetoclax Treatment for Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)",[26],"2026-08-26T02:17:54.420226Z","2026-05-05T02:43:28.496809Z",{"nct_id":49,"title":50,"phases":51,"status":52,"updated_at":53,"content_modified":54},"NCT05589896","A First-in-Human Study of HLA-Partially to Fully Matched Allogenic Cryopreserved Deceased Donor Bone Marrow Transplantation for Patients With Hematologic Malignancies",[12],"ACTIVE_NOT_RECRUITING","2026-08-03T03:35:37.456806Z","2026-05-05T02:43:29.711460Z"]